XERIS BIOPHARMA HOLDINGS INC XERS 5 07.15.25
NOTE 5.000% 7/1 · US DOMESTIC · CUSIP 98422LAA5
6
institutional holders
-1 vs Q1 2023
250.0k
shares reported held*
$53.1mreported value*
0 new
2 added
0 reduced
1 sold out
net bought ≈ $0
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Implied quarter-end price ≈ $212.51.
Trends to Q2 2023
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q3 2022 | 7 |
| Q4 2022 | 7 |
| Q1 2023 | 7 |
| Q2 2023 | 6 |
Buyers vs sellers
Managers adding to or starting a position, vs cutting or selling out
Bought or addedCut or sold out
Numbers
| Quarter | Bought or added | Cut or sold out |
|---|---|---|
| Q4 2022 | 1 | 2 |
| Q1 2023 | 1 | 1 |
| Q2 2023 | 2 | 1 |
Biggest buyers
| LAZARD ASSET MANAGEMENT LLC | Added | +1.0m |
| Sessa Capital IM, L.P. | Added | +1.0m |
Biggest sellers
| ROYAL BANK OF CANADA | Sold out | -2.0m |
Holders, Q2 2023
| Manager | Shares | Change |
|---|---|---|
| DEERFIELD MANAGEMENT COMPANY, L.P. 0.46% of their portfolio | 18.0m $21.4m | Unchanged |
| Sessa Capital IM, L.P. 0.77% of their portfolio | 14.0m $15.4m | Added +1.0m |
| LAZARD ASSET MANAGEMENT LLC 0.02% of their portfolio | 11.5m $12.5m | Added +1.0m |
| 683 Capital Management, LLC 0.34% of their portfolio | 3.0m $3.5m | Unchanged |
| Saltoro Capital, LP 0.73% of their portfolio | 250.0k $272.2k | Unchanged |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0.00% of their portfolio | 0 $0 | Unchanged |